The Makers of the Omnipod® Insulin Management System
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod® product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnipod® technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 140,000 users across the globe rely on Insulet’s Omnipod® Insulin ManagementSystem to bring simplicity and freedom to their lives.
On July 1, 2018, Insulet assumed direct distribution of its Omnipod® Insulin Management System in Europe, including sales, marketing, training and customer support activities. This allows Insulet to be closer to the diabetes community and identify opportunities to support European customer needs over the long-term, as it does in the United States and Canada. European customers can find additional information about our transition at www.omnipodeurope.com and can also register for email updates.
Media and Investor Inquiries
We would be happy to talk to your further. Please contact us via mail, phone, or email:
600 Technology Park Drive, Suite 200
Billerica, MA 01821
Investor and corporate/financial media inquiries: email@example.com
U.S. product-related media inquiries: firstname.lastname@example.org
Media inquiries in Europe: email@example.com
Media inquiries in Canada: firstname.lastname@example.org
*Up to 72 hours of insulin delivery